Pages that link to "Q34546781"
Jump to navigation
Jump to search
The following pages link to Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance (Q34546781):
Displaying 50 items.
- Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma (Q24235977) (← links)
- miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation (Q24655473) (← links)
- New advances in hepatocellular carcinoma (Q26749329) (← links)
- A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016 (Q26752478) (← links)
- Management of hepatocellular carcinoma in the elderly (Q26827161) (← links)
- Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis (Q26864259) (← links)
- Management of "very early" hepatocellular carcinoma on cirrhotic patients (Q26864406) (← links)
- Evolution of hepatitis B management in kidney transplantation (Q26995706) (← links)
- Non-invasive diagnosis of focal liver lesions: an individualized approach (Q26999766) (← links)
- Modulation of RANTES expression by HCV core protein in liver derived cell lines (Q27480801) (← links)
- Association between hepatitis C and hepatocellular carcinoma (Q27491295) (← links)
- Surveillance for hepatocellular carcinoma (Q27690269) (← links)
- Management of HCC (Q28258769) (← links)
- Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges (Q28272678) (← links)
- Microenvironmental regulation of tumor progression and metastasis (Q29615504) (← links)
- In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft. (Q30372076) (← links)
- Current role of ultrasound for the management of hepatocellular carcinoma (Q30488974) (← links)
- Increasing survival of hepatocellular carcinoma patients in Scotland: a review of national cancer registry data (Q30596607) (← links)
- SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma. (Q31149403) (← links)
- Safety and efficacy of sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation (Q33408291) (← links)
- Nuclear beta-catenin induces an early liver progenitor phenotype in hepatocellular carcinoma and promotes tumor recurrence (Q33556420) (← links)
- Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial. (Q33576986) (← links)
- Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classification (Q33590076) (← links)
- Cirrhosis and its complications: evidence based treatment (Q33594931) (← links)
- Regulation of tumor growth and metastasis: the role of tumor microenvironment (Q33734780) (← links)
- Progression of liver cirrhosis to HCC: an application of hidden Markov model (Q33860546) (← links)
- A Comprehensive Analysis of the Dynamic Biological Networks in HCV Induced Hepatocarcinogenesis (Q33883666) (← links)
- Correlations between transmembrane 4 L6 family member 5 (TM4SF5), CD151, and CD63 in liver fibrotic phenotypes and hepatic migration and invasive capacities (Q33916621) (← links)
- Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (≥10 cm) hepatocellular carcinomas: A clinical study (Q33932984) (← links)
- Diffusion-weighted magnetic resonance imaging to predict response of hepatocellular carcinoma to chemoembolization (Q33960387) (← links)
- 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema (Q34064761) (← links)
- Laser ablation for small hepatocellular carcinoma. (Q34108430) (← links)
- Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit (Q34137291) (← links)
- miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway (Q34191243) (← links)
- Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo (Q34268708) (← links)
- TM4SF5-mediated protein-protein networks and tumorigenic roles. (Q34389744) (← links)
- Hepatocellular carcinoma in thalassemia: A critical review (Q34391592) (← links)
- Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil (Q34486973) (← links)
- RETRACTED: Systematic evaluation of percutaneous radiofrequency ablation versus percutaneous ethanol injection for the treatment of small hepatocellular carcinoma: a meta-analysis (Q34544494) (← links)
- Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. (Q34585928) (← links)
- Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. (Q34606896) (← links)
- Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review (Q34623730) (← links)
- MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma (Q34784133) (← links)
- Role of surveillance in prevention of hepatocellular carcinoma (Q34826014) (← links)
- The Indian National Association for Study of the Liver (INASL) Consensus on Prevention, Diagnosis and Management of Hepatocellular Carcinoma in India: The Puri Recommendations (Q34826535) (← links)
- Impact of PIVKA-II in diagnosis of hepatocellular carcinoma (Q34961730) (← links)
- A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration (Q35107005) (← links)
- Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis (Q35122619) (← links)
- Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm. (Q35171592) (← links)
- Risk factors for naturally-occurring early-onset hepatocellular carcinoma in patients with HBV-associated liver cirrhosis in China (Q35173805) (← links)